Personalized Cancer Genome Sequencing Market Global Personalized Cancer Genome Sequencing Marke | Page 2

Asia-Pacific is also expected to emerge as a promising destination for development of the
personalized cancer genome sequencing market in the next few years. This regional market is
expected to exhibit growth at a healthy pace in the next few years. Factors such as the rising
disposable incomes, increased expenditure on healthcare and wellness, and an improving healthcare
infrastructure across developing economies such as India and China will drive the market. The
thriving medical tourism industry in these countries is also expected to be a key driving factor.
However, high costs of personalized cancer genome testing could limit the rate of adoption of this
technique across the region to a certain extent.
Global Personalized Cancer Genome Sequencing Market: Competitive Dynamics
Although the scope of growth of the global personalized cancer genome sequencing market is huge,
the market has witnessed the entry of very few companies owing to the stringent regulatory scenario
governing the development prospects of new solutions and their marketing across regional markets
with differing sets of approval processes. In the next few years as well, this factor is expected to
permit few new players to foray into the global personalized cancer genome sequencing market.
Some of the leading players operating in the market are Ambry Genetics, Beckman Coulter
Genomics, Illumina, Inc., Cofactor Genomics, and BGI Americas Corporation.
Request for brochure of this report -
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12248
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global
business information reports and services. Our exclusive blend of quantitative forecasting and trends
analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team
of analysts, researchers, and consultants, use proprietary data sources and various tools and
techniques to gather, and analyze information. Our business offerings represent the latest and the most
reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals,
energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope
and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Of